Hydrochlorothiazide

Overview

Hydrochlorothiazide is a diuretic medication used to treat high blood pressure and swelling due to fluid build-up. It helps reduce excess fluid in the body and aids in lowering blood pressure.

API suppliers (30)

Suppliers of Hydrochlorothiazide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Ipca Laboratories LimitedIndia2 active DMF
• Unichem Laboratories Ltd.India2 active DMF
• TAPI NL BV2 active DMF
• CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
• Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
• CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
• CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF
• Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
• CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
• VALENS MOLECULES PRIVATE LTD1 active DMF
• Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF
• CTX LIFE SCIENCES PVT LTD1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF
• VALENS MOLECULES PRIVATE LTD1 active DMF
• CTX LIFE SCIENCES PVT LTD1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF
• ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Showing 25 of 30 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (29 approved US products), the latest listed US patent on Hydrochlorothiazide expires 23 Jan 2044. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide

Canonical SMILES

C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl

InChIKey

JZUFKLXOESDKRF-UHFFFAOYSA-N

Therapeutic areas